It’s official, the COVID-19 vaccine produced by pharmaceutical giant Pfizer has been approved by the FDA (the US’s Food and Drug Administration) and will be rolled out throughout the country to fight the pandemic.
The news was announced by CBS News – the US radio and television broadcaster followed the world over – as its breaking evening news, reporting that Pfizer and the government have agreed on the shipment of 3 million frozen doses to reach all areas of the country.
Market leader in the end-of-line packaging sector and technology partner to Pfizer, Robopac will be guaranteeing the vaccine’s packaging and transport safety following its contribution to the development of ad hoc solutions for the packaging of pharmaceutical products made by the American giant.
Ecoplat Plus is the solution adopted by Pfizer for packaging the vaccine doses due to be distributed in the USA.
A significant achievement for everyone, in which Robopac – once again – has played a leading role in an industrial venture with great humanitarian importance.
Advertisement
